Home > Insider Trading > Filing (0001209191-19-059186)

Filing Details

Accession Number:: 0001209191-19-059186
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-12-04 20:00:17
Reporting Period:: 2019-12-02

Accepted Time:: 2019-12-04 20:00:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1731348	Tilray Inc.	TLRY	Medicinal Chemicals & Botanical Products (2833)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1746080	Michael Auerbach	1100 Maughan Road Nanaimo A1 V9X IJ2		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class 2 Common Stock	Acquisiton	2019-12-02	18,750	$7.76	31,875	No	4	M	Direct
Class 2 Common Stock	Disposition	2019-12-02	31,875	$19.05	0	No	4	S	Direct
Class 2 Common Stock	Disposition	2019-12-02	7,537	$19.05	42,928	No	4	S	Indirect	By M3 Ein Sof LLC
Class 2 Common Stock	Disposition	2019-12-02	900	$19.81	42,028	No	4	S	Indirect	By M3 Ein Sof LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	By M3 Ein Sof LLC
No	4	S	Indirect	By M3 Ein Sof LLC

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class 2 Common Stock	Stock Option (Right to Buy)	Disposition	2019-12-02	18,750	$0.00	18,750	$7.76

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
31,250		2028-05-20	No	4	M	Direct

Footnotes

The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.75 to $19.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote 3 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.75 to $19.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote 4 to this Form 4.
The shares vest at the rate of 25% of the shares on the twelve (12) month anniversary of April 1, 2018 (the "Vest Date"), and the remaining shares will vest quarterly thereafter at the rate of 6.25% of the total number of shares on each quarterly anniversary of the Vesting Date thereafter for so long as the Reporting Person remains in Continuous Service (as defined in the Company's 2018 Equity Incentive Plan), such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Date.